CellBion Co., Ltd. (KOSDAQ:308430)
12,750
+740 (6.16%)
At close: Sep 4, 2026
| Market Cap | 164.54B -52.5% |
| Revenue (ttm) | 2.15B -18.4% |
| Net Income | 7.75B |
| EPS | n/a |
| Shares Out | 12.91M |
| PE Ratio | 21.23 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,099 |
| Open | 12,290 |
| Previous Close | 12,010 |
| Day's Range | 12,140 - 12,900 |
| 52-Week Range | 9,930 - 42,200 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |